Press Releases

This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.

Date Title
12/21/18
Summary ToggleQuest Diagnostics Completes Sale of India Diagnostics Services Business to Strand Life Sciences SECAUCUS, N.J. , Dec. 21, 2018 /PRNewswire/ --  Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has completed the sale of its India medical diagnostic service business to Strand Life Sciences, a Bangalore -based specialized Printer Friendly Version
12/19/18
Summary ToggleWorkforce Drug Positivity Rises by Double-Digits in Almost One-Third of U.S. Industry Sectors Examined, According to New Quest Diagnostics Analysis Retail heads list of industries with highest overall positivity Cocaine positivity increases nearly 43 percent in Retail, more than twice the overall increase of the general U.S. workforce SECAUCUS, N.J. , Dec. 19, 2018 /PRNewswire/ -- Drug use by the U.S. Printer Friendly Version
12/04/18
Summary TogglePAMA is Here, But Most Hospitals are Unaware of Its Impact, Study Finds SECAUCUS, N.J. , Dec. 4, 2018 /PRNewswire/ -- Nearly 80 percent of hospital executives surveyed are not at all familiar, or only somewhat familiar, with the Protecting Access to Medicare Act (PAMA) and its impact on hospitals, according to a survey conducted by Modern Healthcare Custom Media on Printer Friendly Version
11/28/18
Summary ToggleQuest Diagnostics to Discuss Strategic Growth Drivers and Financial Outlook at 2018 Investor Day -- Provides outlook for 2019-2022, extending the company's targeted 3-5% revenue compound annual growth rate (CAGR) and updating its adjusted earnings goal to a 4-6% CAGR -- Raises dividend by 6% to an annual rate of $2.12 per share, the company's eighth dividend increase since 2011 -- Updates Printer Friendly Version
11/28/18
Summary ToggleQuest Diagnostics to Build Flagship Laboratory at Visionary Campus in Clifton, New Jersey to Empower Better Health for Patients in Seven States New lab to be the company's largest in country with more than 1,100 employees, featuring innovative design, automation and expanded capacity SECAUCUS, N.J. , Nov. 28, 2018 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, Printer Friendly Version
11/27/18
Summary ToggleQuest Diagnostics to Acquire the Laboratory Services Business of Boyce and Bynum Pathology Laboratories, Expanding Diagnostic Innovation in the Midwest Transaction aims to provide a broader range of clinical and pathology diagnostic services to patients, hospitals and physicians throughout Missouri and surrounding Midwestern states SECAUCUS, N.J. and COLUMBIA, Mo. , Nov. 27, 2018 /PRNewswire/ --  Quest Diagnostics (NYSE: DGX), the world's leading Printer Friendly Version
11/09/18
Summary ToggleQuest Diagnostics to Showcase New Data at the American Heart Association 2018 Scientific Sessions New Findings Demonstrate the Benefit of Using Genetic Markers to Aid Detection of Atrial Fibrillation Research is a Product of Quest's First National Cardiovascular Center of Excellence Based at Cleveland HeartLab SECAUCUS, N.J. , Nov. 9, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the Printer Friendly Version
11/08/18
Summary ToggleMyQuest from Quest Diagnostics Now Supports Health Records on iPhone SECAUCUS, N.J. , Nov. 8, 2018 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that MyQuest, used by more than six million people to see, store and share their results and health information using a smartphone, Printer Friendly Version
11/08/18
Summary ToggleHorizon Expands Laboratory Network, Adding Quest Diagnostics as Preferred Provider - Quest to participate as in-network provider of laboratory services for Horizon Blue Cross Blue Shield of New Jersey plan participants NEWARK, N.J. and SECAUCUS, N.J. , Nov. 8, 2018 /PRNewswire/ -- Horizon Blue Cross Blue Shield of New Jersey (Horizon BCBSNJ) announced today that it is expanding Printer Friendly Version
11/07/18
Summary ToggleQuest Diagnostics, a Pioneer in Consumer Health, Expands Offering with Launch of QuestDirect, a Service that Provides Consumers Access to Lab Testing without Visiting a Doctor's Office QuestDirect Builds on Quest's existing consumer offerings available through the new and improved MyQuest patient platform that lets people access their lab results, schedule appointments and pay bills SECAUCUS, N.J. , Nov. 7, 2018 /PRNewswire/ --  Quest Diagnostics Incorporated (NYSE: DGX), the Printer Friendly Version
11/06/18
Summary ToggleQuest Diagnostics Completes Acquisition of U.S. Laboratory Services Business of Oxford Immunotec Oxford Immunotec's T-SPOT®.TB Tuberculosis and Accutix™ Tick-Borne Disease Testing Services are Part of Quest Diagnostics' Portfolio of Innovative Infectious Disease Diagnostics Tests, Broadening Access in the United States SECAUCUS, N.J. and OXFORD, England and MARLBOROUGH, Mass., Nov. Printer Friendly Version
10/25/18
Summary ToggleQuest Diagnostics and Marin General Hospital to Improve Access to Innovative Diagnostic Services in Northern California Quest to Acquire the Outreach Laboratory Service Operations of Marin General Hospital SECAUCUS, N.J. and GREENBRAE, Calif. , Oct. 25, 2018 /PRNewswire/ --   Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Marin General Hospital , a not-for-profit, Printer Friendly Version
10/23/18
Summary ToggleQuest Diagnostics To Host Investor Day On November 29, 2018 SECAUCUS, N.J. , Oct. 23, 2018 /PRNewswire/ --  Quest Diagnostics  (NYSE: DGX), the world's leading provider of diagnostic information services, will host an Investor Day for institutional investors and financial analysts in New York City on Thursday, November 29, 2018 at The InterContinental New Printer Friendly Version
10/23/18
Summary ToggleQuest Diagnostics Reports Third Quarter 2018 Financial Results -- Third quarter revenues of $1.89 billion, up 1.8% from 2017 -- Third quarter reported diluted EPS of $1.53, up 32.7% from 2017 -- Third quarter adjusted diluted EPS excluding amortization of $1.68, up 25.4% from 2017 -- Updates outlook for full-year 2018. Printer Friendly Version
10/22/18
Summary ToggleQuest Diagnostics Acquires Hurley Medical Center's Outreach Laboratory Services Operation in Central Michigan Relationship to expand access to quality, high value and innovative services for people in Flint and surrounding communities SECAUCUS, N.J. and FLINT, Mich. , Oct. 22, 2018 /PRNewswire/ --  Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today Printer Friendly Version
10/16/18
Summary ToggleQuest Diagnostics to Present New Insights from Genetic Testing at the 2018 American Society of Human Genetics Annual Meeting Four Presentations Reveal Genetic Insights from Quest's Advanced Diagnostics SECAUCUS, N.J. , Oct. 16, 2018 /PRNewswire/ --  Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it will present results of four studies at the 2018 Printer Friendly Version
10/10/18
Summary ToggleQuest Diagnostics Completes Acquisition of Provant Health, Extending Health and Wellness Services Bolsters company's expert screening and intervention services for employers and managed populations SECAUCUS, N.J. , Oct. 10, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its subsidiary, Summit Health Inc. Printer Friendly Version
10/10/18
Summary ToggleQuest Diagnostics Launches the Global Diagnostics Network (GDN) to Improve Healthcare by Increasing Access to Diagnostic Insights Around the World The GDN brings together leading diagnostics services providers to share expertise and drive worldwide diagnostics innovation SECAUCUS, N.J. , Oct. 10, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today jointly with Printer Friendly Version
10/09/18
Summary ToggleQuest Diagnostics Earns Gold Status in National Business Group on Health's Best Employers for Healthy Lifestyles Awards SECAUCUS, N.J. , Oct. 9, 2018 /PRNewswire/ --  Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it received the Gold Award in the 2018 Best Employers for Healthy Lifestyles awards from the National Business Group on Health (NBGH). Printer Friendly Version
10/05/18
Summary ToggleQuest Diagnostics To Release Third Quarter 2018 Financial Results On October 23 SECAUCUS, N.J. , Oct. 5, 2018 /PRNewswire/ --  Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report third quarter 2018 results on Tuesday, October 23, 2018 , before the market opens. It will hold its quarterly Printer Friendly Version
10/05/18
Summary ToggleQuest Diagnostics to Sell India Diagnostics Business to Strand Life Sciences SECAUCUS, N.J. and BANGALORE, India , Oct. 5, 2018 /PRNewswire/ --  Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced an agreement to sell its India medical diagnostics business to Strand Life Sciences, a Bangalore -based specialized Printer Friendly Version
09/27/18
Summary ToggleQuest Diagnostics Acquires PhenoPath, Broadening Access to Advanced Diagnostics PhenoPath deepens Quest's presence in the Pacific Northwest while extending the company's capabilities in anatomic pathology and molecular oncology SECAUCUS, N.J. and SEATTLE , Sept. 27, 2018 /PRNewswire/ --  Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information Printer Friendly Version
09/26/18
Summary ToggleQuest Diagnostics Partners With RMC Health System to Deliver High-Value, Innovative Laboratory Services SECAUCUS , N.J. and ANNISTON, Ala., Sept. 26, 2018 /PRNewswire/ --  Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Regional Medical Center Health System (RMC), a regional health care provider for a five-county service area in northeast Alabama , Printer Friendly Version
09/25/18
Summary ToggleQuest Diagnostics to Acquire U.S. Laboratory Services Business of Oxford Immunotec Acquisition to broaden access to tuberculosis (TB) IGRA blood testing in the United States SECAUCUS, N.J. and OXFORD, England and MARLBOROUGH, Mass. , Sept. 25, 2018 /PRNewswire/ --  Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Oxford Immunotec Printer Friendly Version
09/24/18
Summary ToggleQuest Diagnostics Acquires ReproSource, Extending Into Advanced Fertility Diagnostics Bolsters Quest's leadership in advanced diagnostics for women's and reproductive health SECAUCUS, N.J. and WOBURN, Mass. , Sept. 24, 2018 /PRNewswire/ --  Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has acquired ReproSource, a Printer Friendly Version
09/07/18
Summary ToggleQuest Diagnostics to Speak at the Morgan Stanley Global Healthcare Conference SECAUCUS, N.J. , Sept. 7, 2018 /PRNewswire/ --  Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Morgan Stanley Global Healthcare Conference in New York City.  Stephen Rusckowski , Chairman, Printer Friendly Version
09/06/18
Summary ToggleQuest Diagnostics Health Trends™ Study Finds Drug Misuse Rates Remain Constant at High Levels, and Dangerous Opioid-related Drug Combining Is Prevalent - More than half of Americans tested misused their prescription drugs in 2017 - Among patients in general care, use of non-prescribed medications and illicit drugs declined, but is still prevalent - Among patients in treatment for substance use disorder (SUD), misuse of heroin and prescription Printer Friendly Version
08/17/18
Summary ToggleQuest Diagnostics Declares Quarterly Cash Dividend SECAUCUS, N.J. , Aug. 17, 2018 /PRNewswire/ --  Quest Diagnostics  (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.50 per share, payable on October 22, 2018 to shareholders of record Printer Friendly Version
08/16/18
Summary ToggleQuest Diagnostics Earns Gold Status in American Heart Association's Workplace Health Achievement Index SECAUCUS, N.J. , Aug. 16, 2018 /PRNewswire/ --   Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it achieved gold status in the American Heart Association's 2018 Workplace Health Achievement Index, ranking the company's workplace Printer Friendly Version
07/30/18
Summary ToggleNew Quest Diagnostics Data Shows Lyme Disease Prevalence Increasing and is Now Present in New U.S. States - Number of positive tests for Lyme disease increased significantly between 2016 and 2017. - Historically concentrated in Pennsylvania and New England states, Lyme disease has been detected in each of the 50 United States and the District of Columbia. Printer Friendly Version